tirzepatide for ulcerative colitis Mirikizumab Administered at the Same Time as in Adult Participants With Moderately to Severely Active and Obesity or Overweight: Phase 3b Study (COMMIT-UC) Using GLP-1 meds like Tirzepatide

#Pharma #Healthcare #GLP1 #ObesityCare #Innovation #Teva #NovoNordisk To view or add a comment, sign in BREAKING NEWS Pfizer bets $7.3B on obesity contender Metsera after internal pipeline setbacks Pfizer has just announced a definitive agreement to acquire Metsera, a clinical-stage company focused on obesity treatments

Lower GSH in semen & higher ROS affecting sperm further substantiated by

No receptor has been identified

Severe gastrointestinal issues: Individuals with a history of severe gastrointestinal problems, such as gastroparesis or pancreatitis, should steer clear of this medication, as semaglutide can exacerbate these conditions

Retrieved from Cruz, A